O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.675 EUR 0.14%
Market Cap: 70.8m EUR
Have any thoughts about
Optomed Oyj?
Write Note

Intrinsic Value

OPTOMED's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one OPTOMED stock under the Base Case scenario is 5.861 EUR. Compared to the current market price of 3.675 EUR, Optomed Oyj is Undervalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OPTOMED Intrinsic Value
5.861 EUR
Undervaluation 37%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation Backtest
Optomed Oyj

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for OPTOMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about OPTOMED?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Optomed Oyj

Provide an overview of the primary business activities
of Optomed Oyj.

What unique competitive advantages
does Optomed Oyj hold over its rivals?

What risks and challenges
does Optomed Oyj face in the near future?

Summarize the latest earnings call
of Optomed Oyj.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Optomed Oyj.

Provide P/S
for Optomed Oyj.

Provide P/E
for Optomed Oyj.

Provide P/OCF
for Optomed Oyj.

Provide P/FCFE
for Optomed Oyj.

Provide P/B
for Optomed Oyj.

Provide EV/S
for Optomed Oyj.

Provide EV/GP
for Optomed Oyj.

Provide EV/EBITDA
for Optomed Oyj.

Provide EV/EBIT
for Optomed Oyj.

Provide EV/OCF
for Optomed Oyj.

Provide EV/FCFF
for Optomed Oyj.

Provide EV/IC
for Optomed Oyj.

Show me price targets
for Optomed Oyj made by professional analysts.

What are the Revenue projections
for Optomed Oyj?

How accurate were the past Revenue estimates
for Optomed Oyj?

What are the Net Income projections
for Optomed Oyj?

How accurate were the past Net Income estimates
for Optomed Oyj?

What are the EPS projections
for Optomed Oyj?

How accurate were the past EPS estimates
for Optomed Oyj?

What are the EBIT projections
for Optomed Oyj?

How accurate were the past EBIT estimates
for Optomed Oyj?

Compare the revenue forecasts
for Optomed Oyj with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Optomed Oyj and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Optomed Oyj against its competitors.

Analyze the profit margins
(gross, operating, and net) of Optomed Oyj compared to its peers.

Compare the P/E ratios
of Optomed Oyj against its peers.

Discuss the investment returns and shareholder value creation
comparing Optomed Oyj with its peers.

Analyze the financial leverage
of Optomed Oyj compared to its main competitors.

Show all profitability ratios
for Optomed Oyj.

Provide ROE
for Optomed Oyj.

Provide ROA
for Optomed Oyj.

Provide ROIC
for Optomed Oyj.

Provide ROCE
for Optomed Oyj.

Provide Gross Margin
for Optomed Oyj.

Provide Operating Margin
for Optomed Oyj.

Provide Net Margin
for Optomed Oyj.

Provide FCF Margin
for Optomed Oyj.

Show all solvency ratios
for Optomed Oyj.

Provide D/E Ratio
for Optomed Oyj.

Provide D/A Ratio
for Optomed Oyj.

Provide Interest Coverage Ratio
for Optomed Oyj.

Provide Altman Z-Score Ratio
for Optomed Oyj.

Provide Quick Ratio
for Optomed Oyj.

Provide Current Ratio
for Optomed Oyj.

Provide Cash Ratio
for Optomed Oyj.

What is the historical Revenue growth
over the last 5 years for Optomed Oyj?

What is the historical Net Income growth
over the last 5 years for Optomed Oyj?

What is the current Free Cash Flow
of Optomed Oyj?

Discuss the annual earnings per share (EPS)
trend over the past five years for Optomed Oyj.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Optomed Oyj

Current Assets 17.4m
Cash & Short-Term Investments 12.1m
Receivables 2.6m
Other Current Assets 2.7m
Non-Current Assets 15.8m
PP&E 1.8m
Intangibles 14m
Other Non-Current Assets 14k
Current Liabilities 5.5m
Accounts Payable 3.9m
Short-Term Debt 193k
Other Current Liabilities 1.4m
Non-Current Liabilities 2.8m
Long-Term Debt 2.6m
Other Non-Current Liabilities 271k
Efficiency

Earnings Waterfall
Optomed Oyj

Revenue
14.7m EUR
Cost of Revenue
-4.7m EUR
Gross Profit
10m EUR
Operating Expenses
-14.9m EUR
Operating Income
-5m EUR
Other Expenses
128k EUR
Net Income
-4.9m EUR

Free Cash Flow Analysis
Optomed Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Optomed announced its Q1 results, highlighting FDA clearance for its Aurora AEYE-DS handheld camera. This AI-powered device achieves high efficacy and promises growth in the U.S. market. Despite the FDA milestone, revenue declined by 4.4% due to lagging software and flat device segments. The company is transitioning to a recurring revenue model with monthly subscriptions, boosting long-term prospects. Cash flow was slightly negative, and gross margins dipped due to strategic shifts. The firm is optimistic about future U.S. sales and Chinese market reinvention through a joint venture.

What is Earnings Call?
Fundamental Scores

OPTOMED Profitability Score
Profitability Due Diligence

Optomed Oyj's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative 3-Years Revenue Growth
23/100
Profitability
Score

Optomed Oyj's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

OPTOMED Solvency Score
Solvency Due Diligence

Optomed Oyj's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Long-Term Solvency
Low D/E
73/100
Solvency
Score

Optomed Oyj's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OPTOMED Price Targets Summary
Optomed Oyj

Wall Street analysts forecast OPTOMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTOMED is 6.146 EUR with a low forecast of 5.05 EUR and a high forecast of 7.875 EUR.

Lowest
Price Target
5.05 EUR
37% Upside
Average
Price Target
6.146 EUR
67% Upside
Highest
Price Target
7.875 EUR
114% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for OPTOMED?

Click here to dive deeper.

Dividends

Optomed Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for OPTOMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Optomed Oyj

Country

Finland

Industry

Health Care

Market Cap

65.3m EUR

Dividend Yield

0%

Description

Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

Contact

OULUN
Oulu
Yrttipellontie 1
+35827413380
www.optomed.com

IPO

2019-12-09

Employees

115

Officers

Chief Executive Officer
Mr. Juho Himberg
Founder
Mr. Seppo Henrik Kopsala
CFO, Chief Legal Officer & Secretary of the Board
Mr. Sakari Knuutti

See Also

Discover More
What is the Intrinsic Value of one OPTOMED stock?

The intrinsic value of one OPTOMED stock under the Base Case scenario is 5.861 EUR.

Is OPTOMED stock undervalued or overvalued?

Compared to the current market price of 3.675 EUR, Optomed Oyj is Undervalued by 37%.

Back to Top